Literature DB >> 8734770

A quality of life instrument for adolescents with chronic headache.

J H Langeveld1, H M Koot, M C Loonen, A A Hazebroek-Kampschreur, J Passchier.   

Abstract

We developed a generic Quality of Life (QL) measurement scale for adolescents between 12 and 18 years of age, primarily for use on youngsters with chronic headaches or migraine. The Quality of Life Headache in Youth (QLH-Y) is a 71 item (69 multiple choice items and two visual analogue scales) QL measurement scale. It assesses an individual's QL in six QL subdomains. Study 1 (n = 223) was aimed at item selection and scale construction. Thirteen subscales were developed to cover the four QL subdomains Psychological Functioning, Functional Status, Physical Status and Social Functioning. The QL subdomains Satisfaction with Life in General and Satisfaction with Health were covered by two visual analogue scales. Internal consistency of nearly all the subscales was satisfactory. Study 2 (n = 159) was conducted to evaluate the validity and stability of the QLH-Y. Indications for parent-youth agreement, construct validity and sensitivity for headache and migraine were obtained. Stability coefficients were between 0.47 and 0.72 for the 1-week interval and between 0.31 and 0.60 for the 6-month interval. Nearly all of the QLH-Y subscales appeared to be more sensitive to differences between subjects with headaches and headache-free subjects, while the QL subdomain Functional Status was most sensitive for subjects who had suffered from a recent headache.

Entities:  

Mesh:

Year:  1996        PMID: 8734770     DOI: 10.1046/j.1468-2982.1996.1603183.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  11 in total

Review 1.  Evidence-based assessment of health-related quality of life and functional impairment in pediatric psychology.

Authors:  Tonya M Palermo; Anna C Long; Amy S Lewandowski; Dennis Drotar; Alexandra L Quittner; Lynn S Walker
Journal:  J Pediatr Psychol       Date:  2008-04-22

2.  Headache in school age.

Authors:  G Casucci; R Terlizzi; S Cevoli
Journal:  Neurol Sci       Date:  2014-05       Impact factor: 3.307

3.  The PedsQL 4.0 Generic Core Scales: sensitivity, responsiveness, and impact on clinical decision-making.

Authors:  James W Varni; Michael Seid; Tara Smith Knight; Karen Uzark; Ilona S Szer
Journal:  J Behav Med       Date:  2002-04

4.  Factors associated with migraine-related quality of life and disability in adolescents: a preliminary investigation.

Authors:  Gregg A Tkachuk; Constance K Cottrell; Jessica S Gibson; Francis J O'Donnell; Kenneth A Holroyd
Journal:  Headache       Date:  2003-10       Impact factor: 5.887

5.  The Development and Psychometric Properties of the MSQOL: A Migraine-Specific Quality-of-Life Instrument.

Authors:  S P McKenna; L C Doward; K M Davey
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

6.  The three dimensions of headache impact: pain, disability and affective distress.

Authors:  Kenneth A Holroyd; Peter Malinoski; Katherine M Davis; Gay L Lipchik
Journal:  Pain       Date:  1999-12       Impact factor: 7.926

7.  Parent-proxy and child self-reported health-related quality of life: using qualitative methods to explain the discordance.

Authors:  Elise Davis; Caroline Nicolas; Elizabeth Waters; Kay Cook; Lisa Gibbs; Angela Gosch; Ulrike Ravens-Sieberer
Journal:  Qual Life Res       Date:  2007-03-10       Impact factor: 3.440

8.  Paranasal sinus air suction for immediate pain relief of acute migraine - a randomized, double blind pilot study.

Authors:  S M R Bandara; S Samita; A M Kiridana; D M P U K Ralapanawa; H M M T B Herath
Journal:  BMC Neurol       Date:  2019-10-23       Impact factor: 2.474

9.  Neurosarcoidosis Presenting as Young-Onset Chronic Headache: A Case Report.

Authors:  Barun Kumar Ray; Rahul Kumar Thakur; Anish Kumar Shah; Biplov Adhikari; Dipesh Kumar Mandal; Ranjit Pandey
Journal:  Case Rep Neurol       Date:  2021-10-21

10.  Management of migraine in adolescents.

Authors:  Marielle A Kabbouche; Deborah K Gilman
Journal:  Neuropsychiatr Dis Treat       Date:  2008-06       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.